A Randomized, Double-Blind, Pharmacokinetic Study of Oral Maribavir with Tacrolimus in Stable Renal Transplant Recipients

MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTS

H. W. SOLLINGER · Transplantation · 1995 · 1.4K citations

Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole <scp>l</scp> -Riboside with a Unique Mode of Action

Karen K. Biron, Richard J. Harvey, Stanley C. Chamberlain et al. · Antimicrobial Agents and Chemotherapy · 2002 · 361 citations · Full text

Viral Replication, Unique Mode, Molecular Biology +18

Pharmacodynamics of Oral Ganciclovir and Valganciclovir in Solid Organ Transplant Recipients

Hugh Wiltshire, Carlos V. Payá, Mark D. Pescovitz et al. · Transplantation · 2005 · 193 citations

Phase I Safety and Pharmacokinetic Trials of 1263W94, a Novel Oral Anti-Human Cytomegalovirus Agent, in Healthy and Human Immunodeficiency Virus-Infected Subjects

Laurene H. Wang, Richard Peck, Yin Yin et al. · Antimicrobial Agents and Chemotherapy · 2003 · 132 citations · Full text

Medicinal Chemistry, Adverse Events, Healthy Subjects +13

Pharmacokinetic Profile of Ganciclovir After its Oral Administration and From its Prodrug, Valganciclovir, in Solid Organ Transplant Recipients

Hugh Wiltshire, Sarapee Hirankarn, Colm Farrell et al. · Clinical Pharmacokinetics · 2005 · 126 citations

Pharmacokinetic Profile, Pharmacology, Oral Administration +4